Clinical trial
A Phase 3 Study of PTC923 in Subjects With Phenylketonuria
NCT05099640 is registered in ClinicalTrials.gov with PTC Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3 Study of PTC923 in Subjects With Phenylketonuria
- Lead sponsor
- PTC Therapeutics
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- September 30, 2021
- Completion date
- May 3, 2023
- Enrollment
- 157 (actual)
- Sites
- 43
Conditions
As the registry lists them; a condition with its own page is linked.
phenylketonuria